Injectable semaglutide dosing for type 2 diabetes (Ozempic) begins at 0.25 mg once weekly for four weeks (a dose-escalation period to improve tolerability, not a therapeutic dose), then increases to 0.5 mg weekly
Dehydration can worsen the sensation of feeling cold
The FDA flagged a number of items that it claims are misleading, including theres a lack of clinical data to support the superiority of Ozempic relative to other GLP-1s, and the letter takes aim at small details in the ad, from comedic devices to the color of shirts
With patents for semaglutide and other GLP-1 drugs set to expire in key markets, Indian CDMOs, API makers, and biologics experts are well placed to step in
Use of this information is at your own risk
With the right medical support, it can finally feel different.